arginine has been researched along with ryanodine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Edwards, DH; Griffith, TM | 1 |
Bosnjak, ZJ; Hogan, QH; Kampine, JP; Stadnicka, A; Stekiel, TA | 1 |
Hatano, Y; Kakuyama, M; Mori, K; Nakamura, K; Nishiwada, M; Terasako, K; Toda, H | 1 |
Hughes, AD; Parkinson, NA | 1 |
Giuliani, S; Maggi, CA; Santicioli, P | 1 |
Pessah, IN; Ta, TA | 1 |
Abbs, S; Al-Sarraj, S; Buk, S; Dirksen, RT; Feng, L; Ghassemi, F; Hanna, M; Jungbluth, H; Lane, RJ; Lillis, S; Loy, RE; Matthews, E; Meissner, G; Mills, K; Muntoni, F; Norwood, F; Rose, MR; Sewry, CA; Treves, S; Zhou, H | 1 |
7 other study(ies) available for arginine and ryanodine
Article | Year |
---|---|
Fractal analysis of role of smooth muscle Ca2+ fluxes in genesis of chaotic arterial pressure oscillations.
Topics: Animals; Apamin; Arginine; Arteries; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Membrane; Charybdotoxin; Histamine; In Vitro Techniques; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nonlinear Dynamics; Oscillometry; Potassium Channels; Rabbits; Ryanodine; Scorpion Venoms; Time Factors; Verapamil | 1994 |
Hypoxic contraction of isolated rabbit mesenteric veins. Contribution of endothelium and attenuation by volatile anesthetics.
Topics: Acetylcholine; Animals; Arginine; Endothelium, Vascular; Enflurane; Glycopeptides; Halothane; Hypoxia; In Vitro Techniques; Indomethacin; Isoflurane; Male; Masoprocol; NG-Nitroarginine Methyl Ester; Nicardipine; Norepinephrine; Peptides, Cyclic; Rabbits; Ryanodine; Vasoconstriction | 1995 |
Halothane and enflurane constrict canine mesenteric arteries by releasing Ca2+ from intracellular Ca2+ stores.
Topics: Animals; Arginine; Caffeine; Calcium; Dogs; Enflurane; Fluorescent Dyes; Fura-2; Halothane; In Vitro Techniques; Indomethacin; Isometric Contraction; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Nitroarginine; Ryanodine; Spectrometry, Fluorescence; Vasoconstriction | 1994 |
The mechanism of action of alpha 2-adrenoceptors in human isolated subcutaneous resistance arteries.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Adrenergic alpha-Agonists; Adult; Aged; Analysis of Variance; Arginine; Azepines; Caffeine; Calcium; Calcium Channel Blockers; Chelating Agents; Dihydropyridines; Egtazic Acid; Female; Humans; Isometric Contraction; Male; Middle Aged; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Potassium; Receptors, Adrenergic, alpha-2; Ryanodine; Vascular Resistance | 1995 |
CGRP inhibition of electromechanical coupling in the guinea-pig isolated renal pelvis.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Alkaloids; Animals; Arginine; Calcitonin Gene-Related Peptide; Calcium; Carbazoles; Enzyme Inhibitors; Glyburide; Guinea Pigs; In Vitro Techniques; Indoles; Isoquinolines; Kidney Pelvis; Male; Membrane Potentials; Nitroarginine; Potassium Channels; Ryanodine; Sucrose; Sulfonamides; Terpenes; Tetrodotoxin; Thapsigargin | 1995 |
Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
Topics: Animals; Arginine; Calcium; Cysteine; Disease Models, Animal; Dose-Response Relationship, Drug; In Vitro Techniques; Inhibitory Concentration 50; Malignant Hyperthermia; Muscle, Skeletal; Mutation; Polychlorinated Biphenyls; Protein Binding; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Swine; Tritium | 2007 |
Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
Topics: Adult; Arginine; Caffeine; Calcium; Calcium Channels; Calcium Channels, L-Type; Cell Line, Transformed; DNA Mutational Analysis; Electron Transport Complex IV; Family Health; Female; Humans; Lysine; Male; Membrane Potentials; Muscle, Skeletal; Muscular Diseases; Mutation; NAV1.4 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sodium Channels; Transfection; Tritium | 2010 |